| CAS Number | 1505453-59-7 |
| Catalog Number | AG00AO1B |
| Chemical Name | 2-[8-Chloro-6-(4-chloro-phenyl)-1-Methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetaMide |
| IUPAC Name | 2-[(4S)-6-(4-chlorophenyl)-1-methyl-8-(1-methylpyrazol-4-yl)-4H-[1,2]oxazolo[5,4-d][2]benzazepin-4-yl]acetamide |
| InChI | InChI=1S/C24H20ClN5O2/c1-13-22-18-8-5-15(16-11-27-30(2)12-16)9-19(18)23(14-3-6-17(25)7-4-14)28-20(10-21(26)31)24(22)32-29-13/h3-9,11-12,20H,10H2,1-2H3,(H2,26,31)/t20-/m0/s1 |
| InChI Key | QFLGNZXBWIQDLQ-FQEVSTJZSA-N |
| MDL Number | MFCD28144506 |
| Molecular Formula | C24H20ClN5O2 |
| Molecular Weight | 445.9009 |
| SMILES | N1=C(C2=CC=C(Cl)C=C2)C2=CC(C3=CN(C)N=C3)=CC=C2C2C(C)=NOC=2[C@@H]1CC(N)=O |
| Synonyms | CHEMBL3787075,
1505453-59-7,
SCHEMBL16738337,
BCP28262,
EX-A2280,
BDBM50158612,
CS-7803,
HY-103036,
BET bromodomain inhibitor,cas 1505453-59-7,
4H-Isoxazolo[5,4-d][2]benzazepine-4-acetamide, 6-(4-chlorophenyl)-1-methyl-8-(1-methyl-1H-pyrazol-4-yl)-, (4S)-,
BET bromodomain inhibitor,
2-[8-Chloro-6-(4-chloro-phenyl)-1-methyl-4H-3-oxa-2,5-diaza-benzo[e]azulen-4-yl]-acetamide,
|
| Complexity | 727 |
| Compound Is Canonicalized | Yes |
| Covalently-Bonded Unit Count | 1 |
| Defined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Exact Mass | 445.131g/mol |
| Formal Charge | 0 |
| Heavy Atom Count | 32 |
| Hydrogen Bond Acceptor Count | 5 |
| Hydrogen Bond Donor Count | 1 |
| Isotope Atom Count | 0 |
| Molecular Weight | 445.907g/mol |
| Monoisotopic Mass | 445.131g/mol |
| Rotatable Bond Count | 4 |
| Topological Polar Surface Area | 99.3A^2 |
| Undefined Atom Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| XLogP3 | 3 |
GHS Hazard and Precautionary Statements
Certificate of Analysis
Lot Number